Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106146459A reveals a cost-effective Bilastine synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Patent CN102795993A details a novel synthesis of 2-bromo-6-fluorobenzoic acid via nitration and reduction, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Novel antimony chloride catalyzed route for 4-hydroxyaurone compounds ensuring high purity and scalable production for global pharmaceutical supply chains.
Patent CN112063531B reveals a novel Geotrichum candidum strain for Ticagrelor intermediate synthesis, offering high stereoselectivity and reduced manufacturing costs.
Novel Lewis base catalyzed route offers high purity pharmaceutical intermediates with streamlined supply chain and cost efficiency for global buyers.
Advanced one-pot synthesis of 2-amino-6-chloropurine improves yield and purity for antiviral drug manufacturing, offering cost-effective supply chain solutions.
Patent CN101600713B details a scalable synthesis for HCV protease inhibitors. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel 3+2 coupling route for fondaparinux sodium intermediate ensures high purity and scalable production for global pharmaceutical supply chains.
Novel patent CN117683078A enables cost-effective glycyl-L-glutamine production with superior purity for global pharmaceutical supply chains and procurement teams.
Patent CN115650863A reveals a 4-step route to Venlafaxine HCl with 67% yield. Ideal for cost-effective API manufacturing and scalable supply chains.
Patent CN1352644A discloses selective triazolo[4,3-a]quinazolin-5-ones as potent PDE4 inhibitors. This report analyzes synthesis routes, SAR, and supply chain advantages for respiratory drug development.
Patent CN103224963B reveals marine strain catalysis for high-purity chiral amines. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112299972B reveals a novel Grignard route for esketamine ketone body, offering superior purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN1229372C reveals a novel Reformatsky reaction for Gemcitabine intermediates, offering high selectivity and cost reduction in API manufacturing without chromatography.
Patent CN113788831B reveals a novel copper-catalyzed one-step synthesis of dihydroindolizinopyrrolone derivatives, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel chiral resolving agent enables high-purity (R)-o-chloromandelic acid production. Mature industrial route ensures supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN109706189B reveals enzymatic route for D-chiro-inositol. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel recombinant (R)-ω-transaminase mutant enables high-yield sitagliptin production with superior stereoselectivity and enzyme activity for pharmaceutical supply chains.
Patent CN115536517B reveals high-yield synthesis reducing solvent waste. Enhances supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN115417759A reveals a 3-step nervonic acid synthesis. Discover cost reduction in pharmaceutical intermediates manufacturing and high-purity supply chain solutions.